Our Research Publications
Updated August 2025
| Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
|---|---|---|---|---|---|---|
| Determining the impact of current Canadian stem cell registry policy on donor availability via dynamic registry simulation | Blake JT, Ganz K, Seftel M, Allan D | 2024 | Vox Sang | View Determining the impact of current Canadian stem cell registry policy on donor availability via dynamic registry simulation | Blood operators | Benchmarking and standard setting |
| How I manage major hemorrhage | Callum JL, George RB, Karkouti K | 2024 | Blood | View How I manage major hemorrhage | Health care providers | Benchmarking and standard setting |
| Oncolytic Virus Senecavirus A Inhibits Hepatocellular Carcinoma Proliferation and Growth by Inducing Cell Cycle Arrest and Apoptosis | Gong T, Liu X, Li Q, Branch DR, Loriamini M, Wen W, Shi Y, Tan Q, Fan B, Zhou Z, Li Y, Yang C, Li S, Duan X, Chen L | 2024 | J Clin Transl Hepatol | View Oncolytic Virus Senecavirus A Inhibits Hepatocellular Carcinoma Proliferation and Growth by Inducing Cell Cycle Arrest and Apoptosis | Researchers | Clinical research |
| Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management | Loriamini M, Cserti-Gazdewich C, Branch DR | 2024 | Int J Mol Sci | View Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management | Researchers | Clinical research |
| Advancement of blood donor factors in RBC and blood component therapy using modern practices and methodologies: How to make multifactorial clinical decisions amid growing complexity | William N, Acker JP, Seghatchian J | 2024 | Transfus Apher Sci | View Advancement of blood donor factors in RBC and blood component therapy using modern practices and methodologies: How to make multifactorial clinical decisions amid growing complexity | Blood operators | New or improved product or process |
| Q&A: Restrictive or liberal transfusion strategy in myocardial infarction and anemia | Carson J, Callum J, Sztainert T | 2024 | Blood.ca website | View Q&A: Restrictive or liberal transfusion strategy in myocardial infarction and anemia | Health care providers | Benchmarking and standard setting |
| Transfusion Camp Rwanda 2023: A train-the-trainer workshop establishing locally driven leadership in knowledge translation and sustainability in transfusion medicine education | Nizeyimana F, Pendergrast J, Ntegerejuwampayee A, Lin Y, Kanyamuhunga A, Gashaija C, Masaisa F, Uzamukunda C, Mutuyimana G, Ndicunguye F, Gaseminari A, Mulindwa B, Muyombo T, Chargé S, Skelton T | 2024 | Vox Sang | View Transfusion Camp Rwanda 2023: A train-the-trainer workshop establishing locally driven leadership in knowledge translation and sustainability in transfusion medicine education | Health care providers | Education research |
| Meet the Researcher: Dr. Sandra Ramirez-Arcos | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Meet the Researcher: Dr. Sandra Ramirez-Arcos | General public | Other |
| Summer Fun and Science: The Exciting Return of the CBR Amazing Race | Centre for Blood Research | 2024 | Centre for Blood Research Blog | View Summer Fun and Science: The Exciting Return of the CBR Amazing Race | General public | Other |
| Extended supercooled storage of red blood cells | Isiksacan Z, William N, Senturk R, Boudreau L, Wooning C, Castellanos E, Isiksacan S, Yarmush ML, Acker JP, Usta OB | 2024 | Commun Biol | View Extended supercooled storage of red blood cells | Researchers | Basic research |
| Lay Science Writing Competition 2024: Understanding graft versus host disease (GvHD) | Rosenflanz K | 2024 | Centre for Blood Research Blog | View Lay Science Writing Competition 2024: Understanding graft versus host disease (GvHD) | General public | Other |
| Intravenous Albumin: Is it time to consider de-prescribing efforts? | Wolfe A | 2024 | The ORBCoN Report | View Intravenous Albumin: Is it time to consider de-prescribing efforts? | Health care providers | Benchmarking and standard setting |
| Comprendre l’immunité au Canada : études de séroprévalence de la COVID-19 | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Comprendre l’immunité au Canada : études de séroprévalence de la COVID-19 | General public | Other |
| Améliorer la sécurité du sang en adoptant une approche fondée sur le risque pour la prise de décisions complexes | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Améliorer la sécurité du sang en adoptant une approche fondée sur le risque pour la prise de décisions complexes | General public | Other |
| Atténuer les risques de contamination bactérienne dans la transfusion | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Impact de la recherche | View Atténuer les risques de contamination bactérienne dans la transfusion | General public | Other |
| Higher rates of laboratory-confirmed cases of syphilis in Western Canadian blood donors compared with Eastern Canadian blood donors following a period of societal re-opening | Drews SJ, Charlton C, Tran V, Zhou HY, Hawes G, Resz I, O'Brien SF | 2024 | Vox Sang | View Higher rates of laboratory-confirmed cases of syphilis in Western Canadian blood donors compared with Eastern Canadian blood donors following a period of societal re-opening | Blood operators | Epidemiology research |
| Epidemiology of Hepatitis C over 28 years of monitoring Canadian blood donors: Insight into a low-risk undiagnosed population | O'Brien SF, Ehsani-Moghaddam B, Osmond L, Fan W, Goldman M, Drews SJ | 2024 | BMC Public Health | View Epidemiology of Hepatitis C over 28 years of monitoring Canadian blood donors: Insight into a low-risk undiagnosed population | Health care providers | Epidemiology research |
| Spatial and temporal analysis of West Nile virus infection in mosquito and human populations based on arboviral detection testing data | Talbot B, Ludwig A, O'Brien SF, Drews SJ, Ogden NH, Kulkarni MA | 2024 | Sci Rep | View Spatial and temporal analysis of West Nile virus infection in mosquito and human populations based on arboviral detection testing data | Researchers | Epidemiology research |
| CSTM 2024: Reflections from Canadian Blood Services trainees, part 1 | Yazdanbakhsh M, Paredes C | 2024 | Research.Education.Discovery (R.E.D.) Blog | View CSTM 2024: Reflections from Canadian Blood Services trainees, part 1 | General public | Other |
| Introducing a new blood product to better meet the transfusion needs of the Canadian Armed Forces | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Introducing a new blood product to better meet the transfusion needs of the Canadian Armed Forces | General public | Other |
| Immunoglobulin products | Harding SR, Cowan J, Jennings S | 2024 | Clinical Guide to Transfusion | View Immunoglobulin products | Health care providers | Benchmarking and standard setting |
| Management of Pregnancies Alloimmunized with Non-Rh and Non-K Alloantibodies | Jackson ME, Grabowska K, Lieberman L, Clarke G, Yan MTS, Canadian Obstetric Pediatric Transfusion N | 2024 | J Obstet Gynaecol Can | View Management of Pregnancies Alloimmunized with Non-Rh and Non-K Alloantibodies | Health care providers | Clinical research |
| Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groups | Blake JT, Parmar G, Ganz K, Seftel MD, Allan DS | 2023 | Transfusion | View Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groups | Health care providers | New or improved product or process |
| Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses | Kassardjian A, Sun E, Sookhoo J, Muthuraman K, Boligan KF, Kucharska I, Rujas E, Jetha A, Branch DR, Babiuk S, Barber B, Julien JP | 2023 | Cell Rep | View Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses | Researchers | Basic research |
| Towards the crux of sex-dependent variability in red cell concentrates | William N, Osmani R, Acker JP | 2023 | Transfus Apher Sci | View Towards the crux of sex-dependent variability in red cell concentrates | Researchers | Basic research |
| FAQ: Solvent detergent (S/D) treated plasma (Octaplasma) | Mack J, Gordon R, Romans R, Webert K, Ning S, Zeller M | 2023 | Blood.ca website | View FAQ: Solvent detergent (S/D) treated plasma (Octaplasma) | Health care providers | New or improved product or process |
| Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Stewart T | 2023 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
| Loss of Autophagy Activity during Storage of Hematopoietic Stem Cell Grafts Is Associated with Reduced Potency | Maganti H, Jahan S, Patel J, Kaushal R, McGregor C, Pasha R, Pineault N | 2023 | Blood | View Loss of Autophagy Activity during Storage of Hematopoietic Stem Cell Grafts Is Associated with Reduced Potency | Researchers | Basic research |
| Rapport d’impact annuel 2022-2023 Innovation et gestion du portefeuille | Canadian Blood Services' Innovation & Portfolio Management | 2023 | Blood.ca website | View Rapport d’impact annuel 2022-2023 Innovation et gestion du portefeuille | General public | Other |
| Transfusion thérapeutique de granulocytes | Gardner E, Fernandes M, Latour C, Seftel M, Acker J, Clarke G | 2023 | Guide de la pratique transfusionnelle | View Transfusion thérapeutique de granulocytes | Health care providers | Benchmarking and standard setting |
| Effect of Donor Sex on Recipient Mortality in Transfusion | Chassé M, Fergusson DA, Tinmouth A, Acker JP, Perelman I, Tuttle A, English SW, Hawken S, Forster AJ, Shehata N, Thavorn K, Wilson K, Cober N, Maddison H, Tokessy M | 2023 | NEJM | View Effect of Donor Sex on Recipient Mortality in Transfusion | Researchers | Clinical research |
| Monitoring syphilis serology in blood donors: Is there utility as a surrogate marker of early transfusion transmissible infection behavioral risk? | O'Brien SF, Drews SJ, Yi Q-L, Osmond L, Tran V, Zhou HY, Goldman M | 2023 | Transfusion | View Monitoring syphilis serology in blood donors: Is there utility as a surrogate marker of early transfusion transmissible infection behavioral risk? | Researchers | Benchmarking and standard setting |
| What influences decisions to donate plasma? A rapid review of the literature | Berger M, Easterbrook A, Holloway K, Devine D, Bansback N | 2023 | Vox Sang | View What influences decisions to donate plasma? A rapid review of the literature | Researchers | Ethical, legal & social implications research |
| The impact of biological age of red blood cell on in vitro endothelial activation markers | Alshalani A, Beuger BM, Tuip-de Boer AM, van Bruggen R, Acker JP, Juffermans NP | 2023 | Front Physiol | View The impact of biological age of red blood cell on in vitro endothelial activation markers | Researchers | Basic research |
| The importance of iron for whole blood donors: a Canadian perspective | Khandelwal A, Pambrun C, Goldman M | 2023 | Blood.ca website | View The importance of iron for whole blood donors: a Canadian perspective | Health care providers | Benchmarking and standard setting |
| Chapitre 14. Aphérèse thérapeutique | Oliver M, Patriquin C | 2023 | Guide de la pratique transfusionnelle | View Chapitre 14. Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
| Extracellular vesicles: effectors of transfusion-related acute lung injury | Kuebler WM, William N, Post M, Acker JP, McVey MJ | 2023 | Am J Physiol Lung Cell | View Extracellular vesicles: effectors of transfusion-related acute lung injury | Researchers | Clinical research |
| Auditing a recently implemented massive hemorrhage protocol: feasibility of assessing pre-specified metrics and compliance | Leis M, Clarfield L, Lin Y, Gupta A, Da Luz L | 2023 | CJEM | View Auditing a recently implemented massive hemorrhage protocol: feasibility of assessing pre-specified metrics and compliance | Health care providers | Benchmarking and standard setting |
| KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study | Ning S, Morin PA, Elahie A, Li N, Liu Y, Barty R, Clarke G, Zeller M, Heddle NM | 2023 | Transfusion | View KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study | Health care providers | Clinical research |
| Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study | Hitchon CA, Mesa C, Bernstein CN, Marrie RA, Card C, O’Brien SF, Kim J | 2023 | BMJ Open | View Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study | Health care providers | Clinical research |
| Resource for Physicians: Hemolytic disease of the newborn (HDN): IVIG in the management of Rh- and ABO-mediated HDN | Lieberman L, La Rocca U, Estcourt L, Jug R, Louw V, Muniz-Diaz E, Maier RF, Christensen R, Goel R, Sheharyar R, Delaney M, Bercovitz R, Bake J, Ramsey G, Pessoa dos Santos M, Charge S, Wolfe A, Bathla A, On behalf of the International Collaboration for Transfusion Medicine Guidelines (ICTMG) | 2023 | ICTMG.org | View Resource for Physicians: Hemolytic disease of the newborn (HDN): IVIG in the management of Rh- and ABO-mediated HDN | Health care providers | Benchmarking and standard setting |
| Genetically engineered transfusable platelets using mRNA lipid nanoparticles | Leung J, Strong C, Badior KE, Robertson M, Wu X, Meledeo MA, Kang E, Paul M, Sato Y, Harashima H, Cap AP, Devine DV, Jan E, Cullis PR, Kastrup CJ | 2023 | Sci Adv | View Genetically engineered transfusable platelets using mRNA lipid nanoparticles | Researchers | New or improved product or process |
| An unsupervised learning approach to identify immunoglobulin utilization patterns using electronic health records | Riazi K, Ly M, Barty R, Callum J, Arnold DM, Heddle NM, Down DG, Sidhu D, Li N | 2023 | Transfusion | View An unsupervised learning approach to identify immunoglobulin utilization patterns using electronic health records | Researchers | Benchmarking and standard setting |
| Reconsidering sickle cell trait testing of red blood cell units allocated to children with sickle cell disease | Hajjaj OI, Cserti-Gazdewich C, Dumevska L, Hanna M, Lau W, Lieberman L | 2023 | Transfusion | View Reconsidering sickle cell trait testing of red blood cell units allocated to children with sickle cell disease | Health care providers | Clinical research |
| How do I provide rare red cells to patients? | Laureano M, Clarke G, Yan MTS | 2023 | Transfusion | View How do I provide rare red cells to patients? | Health care providers | Benchmarking and standard setting |
| Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder | Venier LM, Clerici B, Bissola AL, Modi D, Jevtic SD, Radford M, Mahamad S, Nazy I, Arnold DM | 2023 | Int J Hematol | View Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder | Researchers | Clinical research |
| Surveillance Report 2022 | O'Brien S | 2023 | Blood.ca website | View Surveillance Report 2022 | Blood operators | Benchmarking and standard setting |
| La maladie hémolytique du nouveau-né (immunisation antirhésus et anticorps non ABO) | International Collaboration for Transfusion Medicine Guidelines | 2023 | ICTMG.org | View La maladie hémolytique du nouveau-né (immunisation antirhésus et anticorps non ABO) | General public | Other |
| Barriers and enablers to and strategies for pro-moting plasma donation: overarching protocol for three systematic reviews | Etherington C, Palumbo A, Holloway K, Meyer S, Labrecque M, Rubini K, Shorr R, Welch V, Gibson E, Foster T, Haw J, Vesnaver E, Maharshi MT, O'Brien S, MacPherson P, Dogba J, Steed T, Goldman M, Presseau J | 2023 | PsyArXiv | View Barriers and enablers to and strategies for pro-moting plasma donation: overarching protocol for three systematic reviews | Researchers | MSM research |
| Significant rosettes observed in monocyte monolayer assay due to complement-binding antibodies | Sandhu G, Lipman T, Bodnar M, Bienz MN, Branch DR | 2023 | Transfusion | View Significant rosettes observed in monocyte monolayer assay due to complement-binding antibodies | Researchers | Basic research |